US Stock MarketDetailed Quotes

KalVista Pharmaceuticals (KALV)

Watchlist
  • 26.730
  • -0.030-0.11%
Close May 15 16:00 ET
  • 26.745
  • +0.015+0.06%
Post 20:01 ET
1.42BMarket Cap-18.06P/E (TTM)

KalVista Pharmaceuticals (KALV) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Apr 30, 2025
(Q3)Jan 31, 2025
(Q2)Oct 31, 2024
(Q1)Jul 31, 2024
(FY)Apr 30, 2024
(Q4)Apr 30, 2024
(Q3)Jan 31, 2024
(Q2)Oct 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-14.46M
8.53%-81.62M
-167.22%-40.36M
-18.53%-32.68M
-99.96%-39.64M
-50.47%-40.22M
-18.56%-89.23M
33.27%-15.11M
-196.81%-27.57M
3.73%-19.83M
Net income from continuing operations
---23.49M
13.52%-109.52M
-16.97%-52.23M
-67.11%-48.51M
-52.86%-42.27M
-59.75%-40.44M
-36.31%-126.64M
-69.74%-44.65M
-36.26%-29.03M
-24.23%-27.65M
Operating gains losses
--3.3M
390.97%1.64M
-22,348.39%-6.96M
1,127.06%4.48M
-226.68%-774K
-3.10%-731K
61.80%-565K
86.16%-31K
27.45%-436K
155.75%611K
Depreciation and amortization
--355K
18.75%969K
19.18%261K
10.63%229K
15.23%227K
16.06%224K
13.65%816K
16.49%219K
4.02%207K
13.87%197K
Other non cash items
--4.59M
103,166.67%12.37M
337,700.00%3.38M
145,700.00%2.92M
-136.84%-45K
-183.33%-5K
-114.29%-12K
-103.13%-1K
-80.00%2K
-200.00%-19K
Change In working capital
---4.18M
-93.71%954K
-30.53%11.54M
641.96%5.59M
-94.41%213K
45.25%-2.31M
104.60%15.17M
1,364.73%16.61M
-110.47%-1.03M
1,784.96%3.81M
-Change in receivables
---8.68M
-190.53%-7.4M
-131.00%-4.46M
250.00%3.16M
47.26%-1.07M
39.88%-1.25M
453.02%8.18M
429.69%14.39M
-122.93%-2.11M
43.23%-2.03M
-Change in inventory
---665K
---3.43M
----
----
----
----
----
----
----
----
-Change in prepaid assets
---184K
2,103.35%10.78M
11.29%-1.28M
-1,064.14%-1.4M
19.27%2.1M
21.93%-783K
-108.04%-538K
-164.18%-1.44M
-81.65%145K
2.86%1.76M
-Change in payables and accrued expense
---5.37M
-95.18%363K
83.54%6.72M
312.49%3.83M
-120.23%-823K
75.80%-274K
147.75%7.53M
12.74%3.66M
907.83%929K
150.25%4.07M
-Change in other working capital
--10.71M
--643K
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
---14.46M
8.53%-81.62M
-167.22%-40.36M
-18.53%-32.68M
-99.96%-39.64M
-50.47%-40.22M
-18.56%-89.23M
33.27%-15.11M
-196.81%-27.57M
3.73%-19.83M
Investing cash flow
Cash flow from continuing investing activities
-901K
122.05%18.68M
97.36%-3.33M
227.08%8.52M
70.45%48.67M
89.48%37.16M
-304.56%-84.72M
-1,931.98%-126.19M
-166.27%-6.7M
42.08%28.56M
Capital expenditure reported
---82K
52.87%-189K
-118.69%-234K
-13.19%-103K
53.69%-94K
---64K
---401K
---107K
---91K
---203K
Net PPE purchase and sale
---121K
-3,964.29%-1.71M
-1,773.33%-281K
-26.32%-24K
-5,300.00%-108K
-250.00%-21K
96.49%-42K
78.26%-15K
-26.67%-19K
98.96%-2K
Net investment purchase and sale
---698K
124.42%20.58M
97.77%-2.81M
231.13%8.64M
69.93%48.88M
89.85%37.25M
-297.78%-84.28M
-1,952.83%-126.06M
-163.47%-6.59M
41.75%28.76M
Cash from discontinued investing activities
Investing cash flow
---901K
122.05%18.68M
97.36%-3.33M
227.08%8.52M
70.45%48.67M
89.48%37.16M
-304.56%-84.72M
-1,931.98%-126.19M
-166.27%-6.7M
42.08%28.56M
Financing cash flow
Cash flow from continuing financing activities
1.47M
7.91%162.64M
-96.90%4.66M
53,341.20%151.77M
130.47%295K
1,370.59%3M
159.33%150.71M
454,942.42%150.1M
-99.51%284K
-23.81%128K
Net issuance payments of debt
----
--139.05M
----
----
----
----
----
----
----
----
Net common stock issuance
--672K
-99.28%694K
--0
----
----
--0
71.34%96.95M
--96.95M
----
----
Proceeds from stock option exercised by employees
--793K
-97.72%1.23M
-96.52%1.85M
122.54%632K
130.47%295K
1,370.59%3M
3,405.15%53.77M
161,169.70%53.15M
-76.93%284K
-23.81%128K
Net other financing activities
----
--21.67M
--2.81M
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--1.47M
7.91%162.64M
-96.90%4.66M
53,341.20%151.77M
130.47%295K
1,370.59%3M
159.33%150.71M
454,942.42%150.1M
-99.51%284K
-23.81%128K
Net cash flow
Beginning cash position
--230.15M
135.20%132.27M
628.40%167.94M
-27.89%41.58M
-35.54%31.85M
-43.47%31.79M
82.99%56.24M
-72.89%23.06M
49.45%57.67M
30.49%49.41M
Current changes in cash
---13.89M
529.09%99.7M
-543.20%-39.03M
475.44%127.61M
5.27%9.33M
99.16%-58K
-195.74%-23.24M
130.50%8.81M
-173.88%-33.99M
2,800.91%8.86M
Effect of exchange rate changes
---1.68M
-50.95%-1.83M
4,645.95%3.36M
-101.13%-1.25M
167.61%407K
39.29%117K
-198.14%-1.21M
-208.82%-74K
-235.89%-621K
-157.33%-602K
End cash Position
--214.57M
623.98%230.15M
316.09%132.27M
628.40%167.94M
-27.89%41.58M
-35.54%31.85M
-43.47%31.79M
-43.47%31.79M
-72.89%23.06M
49.45%57.67M
Free cash flow
---14.66M
6.87%-83.52M
-168.46%-40.88M
-18.52%-32.81M
-98.92%-39.84M
-50.75%-40.31M
-17.29%-89.67M
32.94%-15.23M
-197.52%-27.68M
3.64%-20.03M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Apr 30, 2025(Q3)Jan 31, 2025(Q2)Oct 31, 2024(Q1)Jul 31, 2024(FY)Apr 30, 2024(Q4)Apr 30, 2024(Q3)Jan 31, 2024(Q2)Oct 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -14.46M8.53%-81.62M-167.22%-40.36M-18.53%-32.68M-99.96%-39.64M-50.47%-40.22M-18.56%-89.23M33.27%-15.11M-196.81%-27.57M3.73%-19.83M
Net income from continuing operations ---23.49M13.52%-109.52M-16.97%-52.23M-67.11%-48.51M-52.86%-42.27M-59.75%-40.44M-36.31%-126.64M-69.74%-44.65M-36.26%-29.03M-24.23%-27.65M
Operating gains losses --3.3M390.97%1.64M-22,348.39%-6.96M1,127.06%4.48M-226.68%-774K-3.10%-731K61.80%-565K86.16%-31K27.45%-436K155.75%611K
Depreciation and amortization --355K18.75%969K19.18%261K10.63%229K15.23%227K16.06%224K13.65%816K16.49%219K4.02%207K13.87%197K
Other non cash items --4.59M103,166.67%12.37M337,700.00%3.38M145,700.00%2.92M-136.84%-45K-183.33%-5K-114.29%-12K-103.13%-1K-80.00%2K-200.00%-19K
Change In working capital ---4.18M-93.71%954K-30.53%11.54M641.96%5.59M-94.41%213K45.25%-2.31M104.60%15.17M1,364.73%16.61M-110.47%-1.03M1,784.96%3.81M
-Change in receivables ---8.68M-190.53%-7.4M-131.00%-4.46M250.00%3.16M47.26%-1.07M39.88%-1.25M453.02%8.18M429.69%14.39M-122.93%-2.11M43.23%-2.03M
-Change in inventory ---665K---3.43M--------------------------------
-Change in prepaid assets ---184K2,103.35%10.78M11.29%-1.28M-1,064.14%-1.4M19.27%2.1M21.93%-783K-108.04%-538K-164.18%-1.44M-81.65%145K2.86%1.76M
-Change in payables and accrued expense ---5.37M-95.18%363K83.54%6.72M312.49%3.83M-120.23%-823K75.80%-274K147.75%7.53M12.74%3.66M907.83%929K150.25%4.07M
-Change in other working capital --10.71M--643K--------------------------------
Cash from discontinued investing activities
Operating cash flow ---14.46M8.53%-81.62M-167.22%-40.36M-18.53%-32.68M-99.96%-39.64M-50.47%-40.22M-18.56%-89.23M33.27%-15.11M-196.81%-27.57M3.73%-19.83M
Investing cash flow
Cash flow from continuing investing activities -901K122.05%18.68M97.36%-3.33M227.08%8.52M70.45%48.67M89.48%37.16M-304.56%-84.72M-1,931.98%-126.19M-166.27%-6.7M42.08%28.56M
Capital expenditure reported ---82K52.87%-189K-118.69%-234K-13.19%-103K53.69%-94K---64K---401K---107K---91K---203K
Net PPE purchase and sale ---121K-3,964.29%-1.71M-1,773.33%-281K-26.32%-24K-5,300.00%-108K-250.00%-21K96.49%-42K78.26%-15K-26.67%-19K98.96%-2K
Net investment purchase and sale ---698K124.42%20.58M97.77%-2.81M231.13%8.64M69.93%48.88M89.85%37.25M-297.78%-84.28M-1,952.83%-126.06M-163.47%-6.59M41.75%28.76M
Cash from discontinued investing activities
Investing cash flow ---901K122.05%18.68M97.36%-3.33M227.08%8.52M70.45%48.67M89.48%37.16M-304.56%-84.72M-1,931.98%-126.19M-166.27%-6.7M42.08%28.56M
Financing cash flow
Cash flow from continuing financing activities 1.47M7.91%162.64M-96.90%4.66M53,341.20%151.77M130.47%295K1,370.59%3M159.33%150.71M454,942.42%150.1M-99.51%284K-23.81%128K
Net issuance payments of debt ------139.05M--------------------------------
Net common stock issuance --672K-99.28%694K--0----------071.34%96.95M--96.95M--------
Proceeds from stock option exercised by employees --793K-97.72%1.23M-96.52%1.85M122.54%632K130.47%295K1,370.59%3M3,405.15%53.77M161,169.70%53.15M-76.93%284K-23.81%128K
Net other financing activities ------21.67M--2.81M----------------------------
Cash from discontinued financing activities
Financing cash flow --1.47M7.91%162.64M-96.90%4.66M53,341.20%151.77M130.47%295K1,370.59%3M159.33%150.71M454,942.42%150.1M-99.51%284K-23.81%128K
Net cash flow
Beginning cash position --230.15M135.20%132.27M628.40%167.94M-27.89%41.58M-35.54%31.85M-43.47%31.79M82.99%56.24M-72.89%23.06M49.45%57.67M30.49%49.41M
Current changes in cash ---13.89M529.09%99.7M-543.20%-39.03M475.44%127.61M5.27%9.33M99.16%-58K-195.74%-23.24M130.50%8.81M-173.88%-33.99M2,800.91%8.86M
Effect of exchange rate changes ---1.68M-50.95%-1.83M4,645.95%3.36M-101.13%-1.25M167.61%407K39.29%117K-198.14%-1.21M-208.82%-74K-235.89%-621K-157.33%-602K
End cash Position --214.57M623.98%230.15M316.09%132.27M628.40%167.94M-27.89%41.58M-35.54%31.85M-43.47%31.79M-43.47%31.79M-72.89%23.06M49.45%57.67M
Free cash flow ---14.66M6.87%-83.52M-168.46%-40.88M-18.52%-32.81M-98.92%-39.84M-50.75%-40.31M-17.29%-89.67M32.94%-15.23M-197.52%-27.68M3.64%-20.03M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More